Literature DB >> 11286016

Neural mechanisms of motion sickness.

N Takeda1, M Morita, A Horii, S Nishiike, T Kitahara, A Uno.   

Abstract

Three kinds of neurotransmitters: histamine, acetylcholine and noradrenaline, play important roles in the neural processes of motion sickness, because antihistamines, scopolamine and amphetamine are effective in preventing motion sickness. Histamine H1-receptors are involved in the development of the symptoms and signs of motion sickness, including emesis. On provocative motion stimuli, a neural mismatch signal activates the histaminergic neuron system in the hypothalamus, and the histaminergic descending impulse stimulates H1-receptors in the emetic center of the brainstem. The histaminergic input to the emetic center through H1-receptors is independent of dopamine D2-receptors in the chemoreceptor trigger zone in the area postrema and serotonin 5HT3-receptors in the visceral afferent, which are also involved in the emetic reflex. Antihistamines block emetic H1-receptors to prevent motion sickness. Scopolamine prevents motion sickness by modifying the neural store to reduce the neural mismatch signal and by facilitating the adaptation/habituation processes. The noradrenergic neuron system in the locus coeruleus is suppressed by the neural mismatch signal. Amphetamine antagonizes mismatch-induced suppression of noradrenergic neural transmission, resulting in preventing motion sickness.

Entities:  

Mesh:

Year:  2001        PMID: 11286016

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  10 in total

Review 1.  The Neurophysiology and Treatment of Motion Sickness.

Authors:  Andreas Koch; Ingolf Cascorbi; Martin Westhofen; Manuel Dafotakis; Sebastian Klapa; Johann Peter Kuhtz-Buschbeck
Journal:  Dtsch Arztebl Int       Date:  2018-10-12       Impact factor: 5.594

2.  Ameliorative Effect of Hesperidin Against Motion Sickness by Modulating Histamine and Histamine H1 Receptor Expression.

Authors:  Uma Maheswari Deshetty; Anand Tamatam; Monojit Bhattacharjee; Ekambaram Perumal; Gopalan Natarajan; Farhath Khanum
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

Review 3.  The role of vagal neurocircuits in the regulation of nausea and vomiting.

Authors:  Tanja Babic; Kirsteen N Browning
Journal:  Eur J Pharmacol       Date:  2013-10-31       Impact factor: 4.432

4.  Rizatriptan reduces vestibular-induced motion sickness in migraineurs.

Authors:  Joseph M Furman; Dawn A Marcus; Carey D Balaban
Journal:  J Headache Pain       Date:  2010-09-23       Impact factor: 7.277

5.  Reconsidering the role of neuronal intrinsic properties and neuromodulation in vestibular homeostasis.

Authors:  Mathieu Beraneck; Erwin Idoux
Journal:  Front Neurol       Date:  2012-02-28       Impact factor: 4.003

6.  Experience-Related Changes in Place Cell Responses to New Sensory Configuration That Does Not Occur in the Natural Environment in the Rat Hippocampus.

Authors:  Dan Zou; Hiroshi Nishimaru; Jumpei Matsumoto; Yusaku Takamura; Taketoshi Ono; Hisao Nishijo
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

7.  Targeting TRPV1 to relieve motion sickness symptoms in mice by electroacupuncture and gene deletion.

Authors:  Chanya Inprasit; Yi-Wen Lin; Chun-Ping Huang; Shu-Yih Wu; Ching-Liang Hsieh
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

8.  Histamine release from intestinal mast cells induced by staphylococcal enterotoxin A (SEA) evokes vomiting reflex in common marmoset.

Authors:  Hisaya K Ono; Shouhei Hirose; Kouji Narita; Makoto Sugiyama; Krisana Asano; Dong-Liang Hu; Akio Nakane
Journal:  PLoS Pathog       Date:  2019-05-21       Impact factor: 6.823

Review 9.  Evaluation of PDE4 inhibition for COPD.

Authors:  Desuo Wang; Xiangli Cui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.